Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Stephen Hoge
Age : 45
Public asset : 239,059,072 USD
Country of residence : Unknown
Linked companies : Moderna, Inc. - Axcella Health Inc.

Biography of Stephen Hoge 
Currently, Stephen Hoge occupies the position of President at Moderna, Inc. and President at ModernaTX, Inc. (a subsidiary of Moderna, Inc.). He is also on the board of Axcella Health, Inc. and President for ModernaTX, Inc. In his past career he was Partner at McKinsey & Co., Inc. He received an undergraduate degree from Amherst College and a doctorate from The University of California, San Francisco.


Current positions of Stephen Hoge 
Holdings of Stephen Hoge 
Stephen Hoge : Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/02ELON MUSK : Musk seeks to put in less money in new Twitter deal financing -sources
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/03Stocks rise, U.S. yields slip as markets await Fed rate hike
RE
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
RE
05/03ELON MUSK : Elon Musk plans to take Twitter public again later - WSJ
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
More news


© 2022 People and Ownership :   
Stephen Hoge : Connections 


Latest news about Stephen Hoge 
05/04INSIDER SELL : Moderna
MT
05/04TRANSCRIPT : Moderna, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Moderna sees higher COVID vaccine sales later this year
RE
04/28TRANSCRIPT : Moderna, Inc. - Shareholder/Analyst Call
CI
04/26INSIDER SELL : Moderna
MT
04/14INSIDER SELL : Moderna
MT
04/05INSIDER SELL : Moderna
MT
More news